Cullari Communications Global
Advertising Networks · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.cullariglobal.comRevenue
$5 MillionIndustry
About Cullari Communications Global
Cullari Communications Global (CCG) is a specialized advocacy and public relations consulting firm dedicated to the life sciences sector, with a focus on fostering collaboration in health advocacy ecosystems worldwide. With 25 years of experience, CCG supports clients in the biopharmaceutical industry, oncology, and rare diseases by optimizing patient advocacy functions and stakeholder engagement. Their Precision Oncology Advocacy Team and R.A.R.E Engagement team provide expert consultation and innovative strategies to enhance patient involvement and improve health outcomes. CCG aims to create positive change for patients and caregivers by ensuring equitable access to clinical trials and fostering strong relationships within the healthcare community.Explore more
SIC Code 87,874NAICS Code 54,541Show moreCullari Communications Global Org Chart
Compare Similar Companies to Cullari Communications Global
Compare insights from companies similar to Cullari Communications Global, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Cullari Communications Global Tech Stack
A closer look at the technologies used by Cullari Communications Global
Top Advertising Networks Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cullari Communications Global
Sign Up For FreeTo access detailed company insights
Cullari Communications Global (CCG) is a specialized advocacy and public relations consulting firm dedicated to the life sciences sector, with a focus on fostering collaboration in health advocacy ecosystems worldwide. With 25 years of experience, CCG supports clients in the biopharmaceutical industry, oncology, and rare diseases by optimizing pati... Read More